GMOV Among Value ETFs
End-of-day Nov 12, 2026 · 77 Value ETFs by YTD
Loading…
Getting the latest data.
GMOUS Stock StylesValue#52 of 694 by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.3% | +0.5% | +2.5% | +2.2% | +22.7% | +27.7% | — | — | +39.0% |
| Peer average | −0.5% | +1.7% | +2.7% | −0.2% | +19.0% | +22.1% | +74.9% | +72.3% | — |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$73 of every $1,000 in GMOV is Microsoft
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MSFTMicrosoft | Technology | 7.28% | $727.63 | 14K | $7.2M |
| 2 | METAMETA Platforms | Communication Services | 5.27% | $526.60 | 8,335 | $5.2M |
| 3 | XOMExxonmobil | Energy | 3.82% | $381.82 | 23K | $3.8M |
| 4 | VZVerizon Communications | Communication Services | 2.47% | $246.84 | 53K | $2.5M |
| 5 | PFEPfizer | Healthcare | 2.42% | $241.63 | 82K | $2.4M |
| 6 | JPMJpmorgan Chase + | Financial Services | 2.28% | $227.52 | 6,594 | $2.3M |
| 7 | MRKMerck + | Healthcare | 2.19% | $219.36 | 15K | $2.2M |
| 8 | REGNRegeneron Pharmaceuticals | Healthcare | 2.12% | $211.79 | 2,197 | $2.1M |
| 9 | BMYBristol Myers Squibb | Healthcare | 2.06% | $206.43 | 33K | $2.1M |
| 10 | BACBank OF America | Financial Services | 2.00% | $199.86 | 39K | $2.0M |
| 11 | CITHE Cigna Group | Healthcare | 1.98% | $198.40 | 6,550 | $2.0M |
| 12 | CVSCVS Health | Healthcare | 1.97% | $196.87 | 22K | $2.0M |
| 13 | ADBEAdobe | Technology | 1.97% | $196.79 | 8,243 | $2.0M |
| 14 | PGRProgressive | Financial Services | 1.78% | $178.48 | 7,606 | $1.8M |
| 15 | ALLAllstate | Financial Services | 1.73% | $172.74 | 6,557 | $1.7M |
of the $465B in 82 Value ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MSFT | Microsoft | 7.28% |
| 2 | META | META Platforms | 5.27% |
| 3 | XOM | Exxonmobil | 3.82% |
| 4 | VZ | Verizon Communications | 2.47% |
| 5 | PFE | Pfizer | 2.42% |
| 6 | JPM | Jpmorgan Chase + | 2.28% |
| 7 | MRK | Merck + | 2.19% |
| 8 | REGN | Regeneron Pharmaceuticals | 2.12% |
| 9 | BMY | Bristol Myers Squibb | 2.06% |
| 10 | BAC | Bank OF America | 2.00% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 30, 2026 | Oct 1, 2026 | $0.17 |
| Jun 30, 2026 | Jul 1, 2026 | $0.13 |
| Mar 31, 2026 | Apr 1, 2026 | $0.17 |
| Dec 30, 2025 | Dec 31, 2025 | $0.14 |
| Sep 30, 2025 | Oct 1, 2025 | $0.15 |
| Jul 1, 2025 | Jul 2, 2025 | $0.15 |
| Mar 31, 2025 | Apr 1, 2025 | $0.10 |
| Dec 30, 2024 | Dec 31, 2024 | $0.0732 |